SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Stock Watcher's Thread / Pix of the Week (POW) -- Ignore unavailable to you. Want to Upgrade?


To: Stock Watcher who wrote (19197)11/17/1999 2:37:00 PM
From: Mr Metals  Respond to of 52051
 
ALERT RMGG CHINA PLAY UNDER .10
ROCKY MOUNTAIN GINSENG, INC. RETAINS SEASONED MERGER AND ACQUISITIONS
VETERAN TO SPEARHEAD ACCELERATED GROWTH PLAN.
8 November 1999
Acquisition Plan Targets Nutritional Supplement Internet Market

Vancouver, Canada--(BUSINESS WIRE)-November 8, 1999-Robert Bell, President
of Rocky Mountain Ginseng, Inc. (OTC BB: RMGG- news), announced today that
the company has retained Mr. Jerry G. Simek as a financial consultant.

Mr. Simek has been President of the JGS Management Group since 1984. Mr.
Simek specializes in strategic planning, financial management,
business/corporate development and mergers & acquisitions. He has
successfully directed and implemented several corporate reorganizations,
financing, acquisition and divestiture programs in the US and Europe for
numerous public companies. Mr. Simek was recently President of a San Diego
based public medical electronics manufacturing company where he facilitated
its turnaround and funding.

Mr. Simek's corporate background includes over thirty years of management
experience with major multinational companies in the medical, energy,
electronics and aerospace industries. He has held key operational and
management positions with several major multinational medical companies
such as Baxter and Johnson & Johnson.

Mr. Simek has facilitated raising capital in a number of public, private
and start-up ventures; has identified and established joint venture
transatlantic manufacturing, trading company and joint licensing programs;
plus established and implemented multi-million dollar project management
and manufacturing expansion programs. He has a BS from Illinois Institute
of Technology and received his MBA, summa cum laude, from Pepperdine
University.

ACQUISITON PLAN

Although committed to its core manufacturing business in China, Rocky
Mountain Ginseng, Inc. intends to capitalize on its expertise in the
nutritional supplement arena, focusing on acquisitions and internet
start-up opportunities in this industry. The company has been approached
by numerous high caliber acquisition candidates and is in the process of
performing the appropriate due diligence to determine the course of action
most advantageous to enhance shareholder value.

"Mr. Simek bring a unique blend of financial management and specialized
business development strategies to the Rocky Mountain Ginseng Inc. team,"
stated Robert Bell, President, Rocky Mountain Ginseng, Inc. "His input and
knowledge will be of extreme value to the company. As we move forward with
the acquisition and growth plan, I look forward to working closely with
Jerry as a core member of our management team," concluded Mr. Bell.

Mr. Simek stated, "The recent success of VitaminShoppe.Com (NASDAQ: VSHP),
PlanetRX.Com (NASDAQ: PLRX), and Drugstore.com (NASDAQ: DSCM) has further
established our desire to enter the nutritional supplement internet arena.
The supplement business here in the U.S. is experiencing tremendous growth
both in the brick and motor model and on the internet. The expertise of
Rocky Mountain Ginseng, Inc. in this arena has attracted some extremely
promising potential acquisition candidates that will hopefully allow Rocky
Mountain Ginseng, Inc. to rapidly bring to market lucrative business
opportunities."

ABOUT ROCKY MOUNTAIN GINSENG, INC.

Rocky Mountain Ginseng, Inc.'s head office is located in British Columbia,
Canada. The company exports American ginseng to China as well as processing
America ginseng products in China. Rocky Mountain Ginseng, Inc. holds
exclusive world processing and distribution rights to several innovative
value added ginseng products developed in North America.

Rocky Mountain Ginseng, Inc. purchased Fuzhou Fujian Drug Company located
in China in February 1999. This acquisition included all necessary drug and
hygiene licenses allowing the company to import, export, manufacture and
distribute ginseng products in all provinces of China. The company has
completed the construction of its new office and manufacturing facility in
the city of Fuzhou and is currently producing traditional ginseng products
for the Chinese Market. The Chinese factory employs 27 people in
processing, sales, accounting and management. Rocky Mountain (Fuzhou) Drug
Co. Ltd. is the first wholly owned American company in the Fujian province.

This press release contains forward-looking statements made pursuant to the
safe harbor provisions of the Private Securities Litigation Act of 1995.
Expression of future goals and similar expressions reflecting something
other than historical fact involve risks and uncertainties. The actual
results the company achieves may differ materially from any forward-looking
statements due to such risks and uncertainties.

CONTACT INFORMATION

Rocky Mountain Ginseng, Inc.
Robert L. Bell, President
(604) 420-0095 phone
email: rlbell@direct.ca
Website: www.direct.ca/ginseng

PMR & Associates, LLC
Patrick Rost, Investor Relations
(760) 942-0015 phone
email: pmrandco@aol.com

JGS Management Group
Jerry Simek, President
(858) 453-0772 phone
email: jgsgroup@aol.com
Rocky Mountain Ginseng, Inc. Completes Construction
of New Manufacturing Facility in China

If You do not use this service
and would like to be removed from this list please send a reply with remove
as the subject.
GOOD LUCK TO ALL

ANDY
DISCLAIMER: THIS IS NOT A SOLICITATION TO BUY OR
SELL STOCKS AND I DO HAVE A RIGHT TO BUY OR SELL THIS OR ANY OTHER STOCK
WITHOUT NOTICE AND THAT EVERYTHING CONTAINED WITHIN IS BELIEVED TO BE
ACCURATE TO THE BEST OF MY KNOWLEDGE AND ALWAYS DO YOUR OWN DD .PLEASE
REMEMBER THESE ARE ONLY MY OPINIONS DO NOT MAKE INVESTMENTS ON MINE OR ANYONE
ELSES OPINIONS DO YOUR OWN RESEARCH. INVESTING IN THE OTC MARKET THOUGH VERY
PROFITABLE TO SOME IS ALSO VERY DANGEROUS. The SEC has issued an investor
alert to help investors evaluate investments promoted on the Internet.
"Internet Fraud" tells investors how to spot fraud and how to use the
Internet to invest wisely and avoid costly mistakes.

"Never, ever, make an investment based solely on what you read in an online
newsletter, E-Mail letter or Internet bulletin board, especially if the
investment involves a small, thinly-traded company that isn't well known,"
said Nancy M. Smith, Director of the SEC's Office of Investor Education and
Assistance. "Assume that the information about these companies is not
trustworthy unless you can prove otherwise through your own independent
research."

"Internet Fraud" is available on the SEC's Web site, at
sec.gov.

PLEASE BE CAREFUL.



To: Stock Watcher who wrote (19197)11/17/1999 3:35:00 PM
From: RCJIII  Read Replies (1) | Respond to of 52051
 
SW, how about another $10 gain for MCOM?

RCJIII